Evaxion shares latest evx-01 phase 2 clinical data in webinar with key opinion leader adnan khattak

Copenhagen, denmark, nov. 06, 2023 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage techbio company specializing in the development of ai-immunology™ powered vaccines, is hosting an online webinar featuring key opinion leader (kol) and study's principal investigator (pi), professor adnan khattak. the webinar will take place on november 8 at 11:30 a.m. est.
EVAX Ratings Summary
EVAX Quant Ranking